First comes news that Dexcom and Verily, Google’s life sciences unit, have amended their partnership agreement. A move we attributed more towards Google being unclear on where they are going then Dexcom not wanting Google as a partner. Partnerships in business like life relationships go through their ups and downs. Therefore, we weren’t that surprised when Dexcom announced they were raising more money.
Per a press release;
“DexCom, Inc. (DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of Convertible Senior Notes due 2023 (the “notes . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.